| 51 |
26470782 | In Vivo Platelet Activation and Aspirin Responsiveness in Type 1 Diabetes. | 2016 Feb |
1 |
| 52 |
26601827 | The IL-1B Genetic Polymorphism Is Associated with Aspirin-Induced PepticUlcers in a Korean Ethnic Group. | 2016 May 23 |
1 |
| 53 |
26859324 | Crystal Structure of Aspirin-Acetylated Human Cyclooxygenase-2: Insight into the Formation of Products with Reversed Stereochemistry. | 2016 Mar 1 |
1 |
| 54 |
27074574 | Aspirin prevents colorectal cancer metastasis in mice by splitting the crosstalk between platelets and tumor cells. | 2016 May 31 |
1 |
| 55 |
27133131 | Mapping the Human Platelet Lipidome Reveals Cytosolic Phospholipase A2 as a Regulator of Mitochondrial Bioenergetics during Activation. | 2016 May 10 |
1 |
| 56 |
27318652 | Interaction between COX-1 and COX-2 Variants Associated with Aspirin Resistance in Chinese Stroke Patients. | 2016 Sep |
1 |
| 57 |
27393450 | A study into the genetic basis of aspirin resistance in Pakistani patients with coronary artery disease. | 2016 Jul |
1 |
| 58 |
27488919 | Development of Poly Unsaturated Fatty Acid Derivatives of Aspirin for Inhibition of Platelet Function. | 2016 Oct |
1 |
| 59 |
27489545 | Asthma and Rhinitis Induced by Selective Immediate Reactions to Paracetamol and Non-steroidal Anti-inflammatory Drugs in Aspirin Tolerant Subjects. | 2016 |
1 |
| 60 |
27515206 | Aspirin for cancer is no mere antiplatelet prototype. There is potential in its ancient roots. | 2016 Sep |
3 |
| 61 |
27554763 | Inhibition of the Biosynthesis of Prostaglandin E2 By Low-Dose Aspirin: Implications for Adenocarcinoma Metastasis. | 2016 Nov |
2 |
| 62 |
27566955 | Systems Pharmacogenomics Finds RUNX1 Is an Aspirin-Responsive Transcription Factor Linked to Cardiovascular Disease and Colon Cancer. | 2016 Sep |
2 |
| 63 |
27683757 | Enhanced platelet MRP4 expression and correlation with platelet function in patients under chronic aspirin treatment. | 2016 Nov 30 |
2 |
| 64 |
27712767 | Mechanisms of Benefit with Aspirin Therapy in Aspirin-Exacerbated Respiratory Disease. | 2016 Nov |
1 |
| 65 |
30551280 | Advances in aspirin-exacerbated respiratory disease (AERD). | 2016 Oct |
1 |
| 66 |
25116182 | Aspirin-responsive, migraine-like transient cerebral and ocular ischemic attacks and erythromelalgia in JAK2-positive essential thrombocythemia and polycythemia vera. | 2015 |
1 |
| 67 |
25307725 | Competition between low-dose aspirin and other NSAIDs for COX-1 binding and its clinical consequences for the drugs' antiplatelet effects. | 2015 Jan |
3 |
| 68 |
25514511 | Mechanistic insights into a classic wonder drug--aspirin. | 2015 Jan 14 |
1 |
| 69 |
25562554 | Management of patients with nonaspirin-exacerbated respiratory disease aspirin hypersensitivity reactions. | 2015 Jan-Feb |
1 |
| 70 |
25604474 | The biological activity of Zeise's salt and its derivatives. | 2015 Feb 23 |
1 |
| 71 |
25638730 | Aspirin inhibits expression of sFLT1 from human cytotrophoblasts induced by hypoxia, via cyclo-oxygenase 1. | 2015 Apr |
3 |
| 72 |
25638779 | Low-dose aspirin (acetylsalicylate) prevents increases in brain PGE2, 15-epi-lipoxin A4 and 8-isoprostane concentrations in 9 month-old HIV-1 transgenic rats, a model for HIV-1 associated neurocognitive disorders. | 2015 May |
3 |
| 73 |
25666703 | New insight into the mechanisms of gastroduodenal injury induced by nonsteroidal anti-inflammatory drugs: practical implications. | 2015 |
1 |
| 74 |
25759598 | New insights into the use of currently available non-steroidal anti-inflammatory drugs. | 2015 |
1 |
| 75 |
25936612 | Aspirin-exacerbated respiratory disease: characteristics and management strategies. | 2015 |
1 |
| 76 |
26139061 | The Multifaceted Clinical Readouts of Platelet Inhibition by Low-Dose Aspirin. | 2015 Jul 7 |
2 |
| 77 |
26149041 | Antiplatelet drugs: which targets for which treatments? | 2015 Jun |
1 |
| 78 |
26245672 | Aspirin for primary prevention in diabetes mellitus: from the calculation of cardiovascular risk and risk/benefit profile to personalised treatment. | 2015 Nov |
2 |
| 79 |
26319435 | Positional isomerism markedly affects the growth inhibition of colon cancer cells by NOSH-aspirin: COX inhibition and modeling. | 2015 Dec |
2 |
| 80 |
26504148 | Oxylipid Profile of Low-Dose Aspirin Exposure: A Pharmacometabolomics Study. | 2015 Oct 26 |
1 |
| 81 |
24205990 | A review of the mechanisms and effectiveness of dietary polyphenols in reducing oxidative stress and thrombotic risk. | 2014 Feb |
2 |
| 82 |
24435454 | Could empirical low-dose-aspirin administration during IVF cycle affect both the oocytes and embryos quality via COX 1-2 activity inhibition? | 2014 Mar |
1 |
| 83 |
24520038 | Repurposing of metformin and aspirin by targeting AMPK-mTOR and inflammation for pancreatic cancer prevention and treatment. | 2014 Apr |
1 |
| 84 |
24605250 | Aspirin, cyclooxygenase inhibition and colorectal cancer. | 2014 Feb 6 |
2 |
| 85 |
24682773 | Aspirin desensitization: useful treatment for chronic rhinosinusitis with nasal polyps (CRSwNP) in aspirin-exacerbated respiratory disease (AERD)? | 2014 Jun |
2 |
| 86 |
24748969 | Aspirin inhibit platelet-induced epithelial-to-mesenchymal transition of circulating tumor cells (Review). | 2014 May |
2 |
| 87 |
24908358 | Aspirin may modify tumor microenvironment via antiplatelet effect. | 2014 Aug |
1 |
| 88 |
24942808 | Reappraisal of the clinical pharmacology of low-dose aspirin by comparing novel direct and traditional indirect biomarkers of drug action. | 2014 Aug |
4 |
| 89 |
24953043 | A computational prospect to aspirin side effects: aspirin and COX-1 interaction analysis based on non-synonymous SNPs. | 2014 Aug |
9 |
| 90 |
25023354 | Platelets, cyclooxygenases, and colon cancer. | 2014 Jun |
1 |
| 91 |
25030064 | COX-1-derived thromboxane A2 plays an essential role in early B-cell development via regulation of JAK/STAT5 signaling in mouse. | 2014 Sep 4 |
1 |
| 92 |
25085874 | Recent prediagnostic aspirin use, lymph node involvement, and 5-year mortality in women with stage I-III breast cancer: a nationwide population-based cohort study. | 2014 Aug 1 |
1 |
| 93 |
25139652 | [Interaction between NSAIDs and acetylsalicylic acid disregarded]. | 2014 |
1 |
| 94 |
25208590 | Effect of aspirin intake at bedtime versus on awakening on circadian rhythm of platelet reactivity. A randomised cross-over trial. | 2014 Dec |
3 |
| 95 |
25243161 | Impact of blood type, functional polymorphism (T-1676C) of the COX-1 gene promoter and clinical factors on the development of peptic ulcer during cardiovascular prophylaxis with low-dose aspirin. | 2014 |
4 |
| 96 |
25439353 | Aspirin or other nonsteroidal inflammatory agent exacerbated asthma. | 2014 Nov-Dec |
1 |
| 97 |
22890587 | Interference of NSAIDs with the thrombocyte inhibitory effect of aspirin: a placebo-controlled, ex vivo, serial placebo-controlled serial crossover study. | 2013 Mar |
2 |
| 98 |
22893199 | Mode of action of aspirin as a chemopreventive agent. | 2013 |
1 |
| 99 |
22893200 | Coxibs: pharmacology, toxicity and efficacy in cancer clinical trials. | 2013 |
1 |
| 100 |
23238666 | High on treatment platelet reactivity against aspirin by non-steroidal anti-inflammatory drugs--pharmacological mechanisms and clinical relevance. | 2013 May |
1 |